Calidi Biotherapeutics (CLDI) Insider Trading & Ownership $0.65 -0.05 (-6.53%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.62 -0.03 (-3.85%) As of 03/28/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Calidi Biotherapeutics (NYSE:CLDI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.28%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$16,200.00 Get CLDI Insider Trade Alerts Want to know when executives and insiders are buying or selling Calidi Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CLDI Insider Buying and Selling by Quarter Remove Ads Calidi Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/17/2024Allan CamaisaCEOSell10,000$1.62$16,200.00 (Data available from 1/1/2013 forward) CLDI Insider Trading Activity - Frequently Asked Questions Who is on Calidi Biotherapeutics's Insider Roster? The list of insiders at Calidi Biotherapeutics includes Allan Camaisa. Learn more on insiders at CLDI. What percentage of Calidi Biotherapeutics stock is owned by insiders? 24.28% of Calidi Biotherapeutics stock is owned by insiders. Learn more on CLDI's insider holdings. Which Calidi Biotherapeutics insiders have been selling company stock? The following insider sold CLDI shares in the last 24 months: Allan Camaisa ($16,200.00). How much insider selling is happening at Calidi Biotherapeutics? Insiders have sold a total of 10,000 Calidi Biotherapeutics shares in the last 24 months for a total of $16,200.00 sold. Calidi Biotherapeutics Key ExecutivesMr. Allan J. Camaisa (Age 64)CEO & Chairman of the Board Compensation: $306.18k1 recent tradesMs. Wendy Pizarro Campbell Esq. (Age 53)Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer & Corporate Secretary Compensation: $295.4kDr. Boris Minev M.D. (Age 61)Ph.D., President of Medical & Scientific Affairs and Interim Chief Medical Officer Compensation: $400.1kMr. Andrew C. Jackson (Age 55)Chief Financial Officer Dr. Amish Patel Ph.D. (Age 47)Senior Vice President of Technical Operations Mr. Stephen Thesing (Age 58)Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies IGM Biosciences Insider Buying Acumen Pharmaceuticals Insider Buying Pyxis Oncology Insider Buying Aerovate Therapeutics Insider Buying MediciNova Insider Buying Corbus Pharmaceuticals Insider Buying Assertio Insider Buying Alto Neuroscience Insider Buying Skye Bioscience Insider Buying Aligos Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NYSE:CLDI) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calidi Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calidi Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLDI Stock Free CLDI Stock Alerts